Cardiovascular diseases

2024 Activity indicators

2 competitive European projects led: RETENTION (H2020) y STRATIFY-HF (HE)
6 national public projects led: ISCIII, MICINN
9 private projects led
54 clinical trials led
95 publications
IF: 808.37
Q1 publications: 59 (62%)
D1 publications: 37 (39%)
3 thesis
2 awards/recognitions
Members of editorial committees: 5 researchers
1 international patent (EP11845312,5) "Possible use of EMMPRIN inhibitors for the treatment of cardiac damage after ischemia-reperfusion" (Authors: Dr. Carlos Zaragoza et al.) and another in application phase

First European Lump Sum financing project awarded "FH-EARLY 101155885: New strategies for the EARLY diagnosis, risk stratification and co-management of familial hypercholesterolemia".
CIBER - SPANISH I study. Prospective, randomized, multicenter, open-label, event-driven study to evaluate the non-inferiority of a personalized precision strategy for the prevention of sudden death in patients with non-ischemic dilated cardiomyopathy. PI in our center: Dr. Marta Jiménez-Blanco.
First European project of the ERASMUS program awarded. "XiA: Xpanding Innovative Alliance for interoperability skills in digital health".
Dr. Cristina Lozano appointed President of the Young Cardiologists Group of the Spanish Society of Cardiology.
Dr. Zamorano obtains various appointments and recognitions, including: Academician of the Royal National Academy of Medicine of Spain, Director of the European PCR TRICUSPID Focus Group, Co-Director of the Interventional Echocardiography Congress (Milan, 2024).

	Articles	Accum. IF	Mean IF	Articles Q1 or Q2	% in Q1 or Q2	Articles D1	% in D1
2020	87	372.38	4.28	48	55	14	16
2021	95	637.15	6.71	73	77	20	21
2022	102	999.40	9.80	74	73	30	29
2023	83	567.62	6.60	64	74	15	17
2024	95	808.37	8.51	69	73	37	39
	465	3384.92	7.18	328	71	116	25